1. Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP. Issue 4 (12th February 2019) Authors: Kari, Esa; Teppo, Hanna-Riikka; Haapasaari, Kirsi-Maria; Kuusisto, Milla Elvi Linnea; Lemma, Aurora; Karihtala, Peeter; Pirinen, Risto; Soini, Ylermi; Jantunen, Esa; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi Journal: Journal of clinical pathology Issue: Volume 72:Issue 4(2019) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020. (13th December 2022) Authors: Harmanen, Minna; Hujo, Mika; Sund, Reijo; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Klaavuniemi, Tuula; Kari, Esa; Jantunen, Esa; Sunela, Kaisa; Rajamäki, Aino; Alanne, Erika; Kuitunen, Hanne; Sancho, Juan‐Manuel; Jukkola, Arja; Rönkä, Aino; Kuittinen, Outi Journal: British journal of haematology Issue: Volume 201:Number 1(2023) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗